Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Calvo Martínez, Lourdes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2755

PMID: 26416999

DOI: 10.1200/jco.2015.61.9510

ISSN: 0732-183x

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

Journal Of Clinical Oncology

Type of content

Artigo